| Similar Articles |
|---|
 |
The Motley Fool
November 7, 2006
Michael P. Cecil |
Will a 10-Bagger Go Higher? Cambridge Heart has a special EKG machine that helps determine which patients need defibrillators. The stock is up tenfold in the past 12 months. After results of a major trial are announced, will the share price go higher?   |
BusinessWeek
March 7, 2005
Michael Arndt |
"Pacemakers" for the Rest of You Slews of tiny devices that deliver electrical stimulation to a wide variety of organs should soon become available. |
BusinessWeek
March 7, 2005
Michael Arndt |
Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market. |
The Motley Fool
June 24, 2009
Brian Orelli |
Boston Scientific Helps Itself ... and Its Rivals Boston Scientific released positive results from a clinical trial testing its heart devices, but unfortunately the data is likely to help its competitors as well. |
Nursing
March 2009
Kate J. Morse |
Focusing on the Surgical Patient with Cardiac Problems Learn about the latest guidelines for assessing cardiac risk and protecting his heart during noncardiac surgery. |
The Motley Fool
March 29, 2011
Brian Orelli |
Medtronic's Exciting New Toys The device maker received multiple approvals in less than a week. |
The Motley Fool
February 17, 2009
Brian Orelli |
Investors Heart Medtronic The leaner company is more lovable. |
The Motley Fool
December 31, 2007
Brian Orelli |
Boston Scientific Restarts Its Heart Boston Scientific receives European approval for its defibrillator, giving the company a revenue boost even if the U.S. approval is delayed. |
BusinessWeek
September 9, 2010
Michelle Cortez |
Coming Soon: Dissolvable Stents New stents from Abbott Labs and others appear to reduce the risk of blood clots |
BusinessWeek
July 5, 2004 |
The Heart Is Just the Start CEO Art Collins explains how Medtronics is moving into treating spinal injuries, neurological disorders, diabetes, and more. |
Inc.
October 1, 2009
Adam Bluestein |
The Future of the Human Body Ten innovations that will improve quality of life - and bring down health care costs. |
Managed Care
May 2005 |
Microcircuit Devices Deliver Considerable Relief From Chronic Pain Recent advances in pain relief revolve around longer-lasting implantable devices. Can managed care afford not to have a pain management strategy? |
BusinessWeek
July 5, 2004
Michael Arndt |
High Tech -- And Handcrafted Despite a recent recall, medical-products maker Medtronic sets the quality standard for heart care. |
American Journal of Nursing
May 2009
Kristen J. Overbaugh |
Acute Coronary Syndrome Coronary artery disease, in which atherosclerotic plaque builds up inside the coronary arteries and restricts the flow of blood (and therefore the delivery of oxygen) to the heart, continues to be the number-one killer of Americans. |
Nursing Management
May 2011
Kirsten Drake |
SCIP core measures: Deep impact In August 2005, the SIP project grew to become a multiyear, national quality partnership of organizations called the Surgical Care Improvement Project, or SCIP, with the goal of decreasing surgical complication by 25% by 2010. |
The Motley Fool
October 23, 2006
Michael P. Cecil |
Are Pacemaker Prices Heading for a Fall? Medicare law changes may drive the amount that hospitals can pay for pacemakers. Will device makers be forced to lower prices? Investors, take note. |
Fast Company
May 2009
Chuck Salter |
The Doctor of the Future Cost, access, quality -- the prognosis for American health care may look grim, but innovation is the cure. The medicine of tomorrow is being born today. |
HBS Working Knowledge
November 22, 2004
Martha Lagace |
Trouble Ahead: Ethics and Medical Devices Medical devices are highly lucrative, especially orthopedic implants. But how ethical are the common selling practices? That question was asked at the 5th Annual Alumni Healthcare Conference. |
Pharmaceutical Executive
June 1, 2014
Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
Pharmaceutical Executive
November 1, 2013
Ben Comer |
Top Medical Innovations for 2014 At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability. |
Fast Company
July 2009
Kate Rockwood |
How the Networked Body Is Reinventing the Consumer A short conversation with Leslie Saxon, who has worked in the field of networked health monitoring for 17 years. |
IEEE Spectrum
March 2006
Samuel K. Moore |
Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed. |
IEEE Spectrum
October 2011
Joseph M. Smith |
Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon |
The Motley Fool
October 20, 2009
Robert Steyer |
The Heart Company's Disheartening Forecast Boston Scientific scaled back its full-year forecast, and the market doesn't like it. |
Nursing
December 2011
Judith A. Nagle |
Getting "hip" to hip hemiarthroplasty This article discusses arthroplasty, the surgery used to restore motion to a joint and function to the muscles, ligaments, and other soft tissues that control the joint. |
The Motley Fool
August 22, 2007
Ryan Fuhrmann |
Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%. |
BusinessWeek
July 18, 2005
John Carey |
Is Heart Surgery Worth It? Physicians are questioning whether bypasses and angioplasties necessarily prolong patients' lives. |
Nursing Management
May 2010
Urbanowicz & Taylor |
Hybrid OR: Is it in your future? Having the availability of a hybrid suite creates new opportunities to combine endovascular and open surgery into one operative episode. |
Nurse Practitioner
December 2011 |
Managing pain in obese patients Obesity-related pain conditions can limit the patient's efforts at increasing activity and limit quality of life. This article will offer information on these conditions and treatment options. |
BusinessWeek
October 29, 2007
Arlene Weintraub |
Medtronic's Uncertain Endeavor The drug-coated stent might have made up for Medtronic's recent product recall, but renewed scrutiny of the device has executives scaling back expectations |
BusinessWeek
July 18, 2005 |
A Coronary Conundrum Four medical experts weigh in on whether heart surgery prolongs patients' lives or only relieves suffering. |
The Motley Fool
August 24, 2010
Brian Orelli |
Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm. |
The Motley Fool
March 2, 2011 |
Fool Q&A: Medtronic CFO Gary Ellis The medical-device maker's chief financial officer talks R&D, "One Medtronic," and growth in emerging markets. |
Pharmaceutical Executive
September 1, 2012
Al Topin |
Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty. |
The Motley Fool
April 23, 2011 |
St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
The Motley Fool
May 26, 2004
Alyce Lomax |
Medtronic Takes Heart After the stock drops on data, what does the company have to say? |
Nursing
September 2011
Jacqueline Harden |
Take a cool look at therapeutic hypothermia Therapeutic hypothermia may help prevent or minimize neurologic impairment in certain patients after cardiac arrest. This article takes a look at when TH is used and how to care for patients who are undergoing this intervention. |
American Journal of Nursing
January 2010 |
Life-Support Interventions at the End of Life: Unintended Consequences Nurses need to be knowledgeable life-support interventions at the end of life and able to communicate what they know about those consequences to patients, family members, and others on the health care team, leading to better decision making at this difficult time. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
HBS Working Knowledge
August 10, 2015
Michael Blanding |
New Medical Devices Get To Patients Too Slowly The FDA has streamlined drug testing to ensure new therapies come to market quickly. But when it comes to life-giving medical devices, approvals seem unnecessarily slow, according to research by Ariel Dora Stern. |
The Motley Fool
October 4, 2004
Selena Maranjian |
When Medicare Boosts Stocks More defibrillators in use means higher earnings for some investors. |
BusinessWeek
June 9, 2009
John Carey |
Giving Patients the Data They Need A growing effort by doctors, insurers, and politicians helps people make better-informed medical decisions |
Salon.com
March 2, 2001
Dawn MacKeen |
Your heart has been recalled In the brave new world of body-part implants, what happens when you get a lemon of a ticker? |
The Motley Fool
June 30, 2011
Brian Orelli |
Medical-Device Makers' Killer: Health-Care Inflation High prices have painted their targets. |
The Motley Fool
February 17, 2005
Stephen D. Simpson |
Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock? |
The Motley Fool
March 31, 2010
Brian Orelli |
How Do You Put a Price on Pain? Price controls could wreck havoc on expensive therapies that control pain. |
BusinessWeek
March 7, 2005 |
Dr. Oesterle's Stimulating Work Medtronic's chief medical officer, Dr. Stephen N. Oesterle, discusses the progress and potential of using "implanted pulse generators" to treat chronic ailments. |
The Motley Fool
May 26, 2005
Stephen D. Simpson |
A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges? |
The Motley Fool
April 20, 2005
Stephen D. Simpson |
St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well. |
